Stay updated on Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.

Latest updates to the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page
- Check4 days agoChange DetectedThe changes appear limited to layout and formatting updates with no modifications to core study details such as purpose, endpoints, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check32 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%

- Check39 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0; overall content remains the same except the revision identifier.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and specific locations in Brazil, while also removing previous location details and various drug classifications.SummaryDifference5%

Stay in the know with updates to Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.